scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.BBMT.2017.02.004 |
P698 | PubMed publication ID | 28192251 |
P50 | author | Andrew Y. Koh | Q38322423 |
Milan R Savani | Q88402232 | ||
P2093 | author name string | David E Greenberg | |
Yang Xie | |||
Minsoo Kim | |||
Xiaowei Zhan | |||
Stella M Davies | |||
Jiwoong Kim | |||
Carlos Arana | |||
Gauri Sunkersett | |||
Laura A Coughlin | |||
Tiffany R Simms-Waldrip | |||
P2860 | cites work | Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile. | Q35163017 |
P433 | issue | 5 | |
P921 | main subject | antibiotic | Q12187 |
P304 | page(s) | 820-829 | |
P577 | publication date | 2017-02-09 | |
P1433 | published in | Biology of Blood and Marrow Transplantation | Q15754328 |
P1476 | title | Antibiotic-Induced Depletion of Anti-inflammatory Clostridia Is Associated with the Development of Graft-versus-Host Disease in Pediatric Stem Cell Transplantation Patients | |
P478 | volume | 23 |
Q90666975 | A gut microbiota score predicting acute graft-versus-host disease following myeloablative allogeneic hematopoietic stem cell transplantation |
Q49817055 | Advances in intestinal microbiota and graft versus host disease |
Q91254526 | Associations between febrile neutropenia-related parameters and the risk of acute GVHD or non-relapse mortality after allogeneic hematopoietic stem cell transplantation |
Q99212162 | Composition of the murine gut microbiome impacts humoral immunity induced by rabies vaccines |
Q38697681 | Consecutive stimulation of HBsAg promotes the viability of the human B lymphoblastoid cell line IM-9 through regulating the SIRT1-NF-κB pathway |
Q64119352 | Early gut microbiota signature of aGvHD in children given allogeneic hematopoietic cell transplantation for hematological disorders |
Q89777592 | Empiric antibiotic use in allogeneic hematopoietic cell transplantation: should we avoid anaerobe coverage? |
Q92556893 | Gut Microbiota Modulation for Multidrug-Resistant Organism Decolonization: Present and Future Perspectives |
Q87913576 | Gut decontamination during allogeneic hematopoietic stem cell transplantation and the risk of acute graft-versus-host disease |
Q49958101 | Gut microbiota injury in allogeneic haematopoietic stem cell transplantation |
Q89108835 | High gastrointestinal microbial diversity and clinical outcome in graft-versus-host disease patients |
Q89496342 | Insights into the role of intestinal microbiota in hematopoietic stem-cell transplantation |
Q61814283 | Intestinal Microbiota Influence Immune Tolerance Post Allogeneic Hematopoietic Cell Transplantation and Intestinal GVHD |
Q55398415 | Intestinal Microbiota at Engraftment Influence Acute Graft-Versus-Host Disease via the Treg/Th17 Balance in Allo-HSCT Recipients. |
Q41693862 | Metagenomic Shotgun Sequencing and Unbiased Metabolomic Profiling Identify Specific Human Gut Microbiota and Metabolites Associated with Immune Checkpoint Therapy Efficacy in Melanoma Patients |
Q40129363 | Potential for Monitoring Gut Microbiota for Diagnosing Infections and Graft-versus-Host Disease in Cancer and Stem Cell Transplant Patients. |
Q47709323 | Rethinking Antimicrobial Prophylaxis in the Transplant Patient in the World of Emerging Resistant Organisms-Where Are We Today? |
Q92580247 | Seeking biomarkers for acute graft-versus-host disease: where we are and where we are heading? |
Q90975320 | Should we evaluate intestinal microbiota of pediatric patients undergoing hematopoietic stem cell transplantation? |
Q90098536 | Specific gut microbiome members are associated with distinct immune markers in pediatric allogeneic hematopoietic stem cell transplantation |
Q57028383 | The Gut Microbiota and Hematopoietic Stem Cell Transplantation: Challenges and Potentials |
Q52689883 | The Microbiome and Hematopoietic Cell Transplantation: Past, Present, and Future. |
Q60938384 | The Role of Co-stimulatory/Co-inhibitory Signals in Graft-vs.-Host Disease |
Q91664568 | The gut microbiota and graft-versus-host disease |
Q40153463 | The microbiome in hematopoietic stem cell transplant recipients and cancer patients: Opportunities for clinical advances that reduce infection |
Search more.